All
Better Quality of Life Reported with Minimally Invasive Esophageal Cancer Treatment
January 23rd 2023Patients who underwent minimally invasive treatment tended to have better quality-of-life outcomes than those who had a full esophagus removal, though there were risk factors for long-term outcomes that should be considered.
Novel Drug-Chemo Combo May Offer ‘New Standard of Care’ for Certain GI Cancers
January 21st 2023Zolbetuximab plus mFOLFOX6 lengthened the time to progression for patients with CLDN18.2-positive, HER2-negative locally advanced unresectable or metastatic gastric/gastroesophageal junction (GEJ) adenocarcinoma.
Immunotherapy Plus Chemo Boosts Event-Free Survival in Resectable Lung Cancer
January 18th 2023Patients with operable non-small cell lung cancer who were treated with an anti-PD-1 monoclonal antibody plus a doublet chemotherapy regiment did not experience cancer recurrence or new symptom onset during follow-up in a recent study.
Beta-Blockers May Improve Post-Surgical Survival in Women With Ovarian Cancer, Heart Conditions
January 18th 2023Women who were taking beta-blockers, a medicine to treat heart conditions like high blood pressure, among others, near the time of surgery for epithelial ovarian cancer may confer a survival benefit years after undergoing a procedure.